
The Food and Drug Administration (FDA) has greenlit a new type of pain medication for the first time in more than 20 years. What's more, the new painkiller doesn't include opioids like many painkillers currently on the market do.
The FDA announced Thursday (Jan. 30) that it had approved the new class of prescription painkiller called suzetrigine, sold under the brand name Journavx.